- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
Annals of clinical and translational neurology. - 6, 8 (2019) , 1487-1497, ISSN: 2328-9503
- Schlagwort
-
Myotonische Dystrophie
- Ereignis
-
Veröffentlichung
- (wo)
-
Freiburg
- (wer)
-
Universität
- (wann)
-
2019
- Urheber
-
Jimenez-Moreno, Cecilia
Nikolenko, Nikoletta
Kierkegaard, Marie
Blain, Alasdair P.
Newman, Jane
Massey, Charlotte
Moat, Dionne
Sodhi, Jas
Atalaia, Antonio
Gorman, Grainne
Turner, Chris
Lochmüller, Hanns
- DOI
-
10.1002/acn3.50845
- URN
-
urn:nbn:de:bsz:25-freidok-1508353
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:56 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Jimenez-Moreno, Cecilia
- Nikolenko, Nikoletta
- Kierkegaard, Marie
- Blain, Alasdair P.
- Newman, Jane
- Massey, Charlotte
- Moat, Dionne
- Sodhi, Jas
- Atalaia, Antonio
- Gorman, Grainne
- Turner, Chris
- Lochmüller, Hanns
- Universität
Entstanden
- 2019
Ähnliche Objekte (12)
Eight years after an international workshop on myotonic dystrophy patient registries: case study of a global collaboration for a rare disease
Correction to: Eight years after an international workshop on myotonic dystrophy patient registries: case study of a global collaboration for a rare disease
The TREAT‐NMD DMD global database: analysis of more than 7,000 duchenne muscular dystrophy mutations
Clinical outcomes in Duchenne Muscular Dystrophy: a study of 5345 patients from the TREAT-NMD DMD global database
Tumor necrosis factor receptor SF10A (TNFRSF10A) SNPs correlate with corticosteroid response in duchenne muscular dystrophy
Life expectancy at birth in Duchenne muscular dystrophy: a systematic review and meta-analysis
Health-related quality of life in patients with adult-onset myotonic dystrophy Type 1: a systematic review
Comparative proteomic analyses of Duchenne muscular dystrophy and Becker muscular dystrophy muscles: changes contributing to preserve muscle function in Becker muscular dystrophy patients
The clinical spectrum of the congenital myasthenic syndrome resulting from COL13A1 mutations
A guide to writing systematic reviews of rare disease treatments to generate FAIR-compliant datasets: building a Treatabolome
Recommendations for improving the quality of rare disease registries
Correction to: A guide to writing systematic reviews of rare disease treatments to generate FAIRcompliant datasets: building a Treatabolome
Eight years after an international workshop on myotonic dystrophy patient registries: case study of a global collaboration for a rare disease
Correction to: Eight years after an international workshop on myotonic dystrophy patient registries: case study of a global collaboration for a rare disease
The TREAT‐NMD DMD global database: analysis of more than 7,000 duchenne muscular dystrophy mutations
Clinical outcomes in Duchenne Muscular Dystrophy: a study of 5345 patients from the TREAT-NMD DMD global database
Tumor necrosis factor receptor SF10A (TNFRSF10A) SNPs correlate with corticosteroid response in duchenne muscular dystrophy
Life expectancy at birth in Duchenne muscular dystrophy: a systematic review and meta-analysis
Health-related quality of life in patients with adult-onset myotonic dystrophy Type 1: a systematic review
Comparative proteomic analyses of Duchenne muscular dystrophy and Becker muscular dystrophy muscles: changes contributing to preserve muscle function in Becker muscular dystrophy patients
The clinical spectrum of the congenital myasthenic syndrome resulting from COL13A1 mutations
A guide to writing systematic reviews of rare disease treatments to generate FAIR-compliant datasets: building a Treatabolome
Recommendations for improving the quality of rare disease registries
Correction to: A guide to writing systematic reviews of rare disease treatments to generate FAIRcompliant datasets: building a Treatabolome
Eight years after an international workshop on myotonic dystrophy patient registries: case study of a global collaboration for a rare disease
Correction to: Eight years after an international workshop on myotonic dystrophy patient registries: case study of a global collaboration for a rare disease
The TREAT‐NMD DMD global database: analysis of more than 7,000 duchenne muscular dystrophy mutations
Clinical outcomes in Duchenne Muscular Dystrophy: a study of 5345 patients from the TREAT-NMD DMD global database
Tumor necrosis factor receptor SF10A (TNFRSF10A) SNPs correlate with corticosteroid response in duchenne muscular dystrophy
Life expectancy at birth in Duchenne muscular dystrophy: a systematic review and meta-analysis
Health-related quality of life in patients with adult-onset myotonic dystrophy Type 1: a systematic review
Comparative proteomic analyses of Duchenne muscular dystrophy and Becker muscular dystrophy muscles: changes contributing to preserve muscle function in Becker muscular dystrophy patients
The clinical spectrum of the congenital myasthenic syndrome resulting from COL13A1 mutations
A guide to writing systematic reviews of rare disease treatments to generate FAIR-compliant datasets: building a Treatabolome
Recommendations for improving the quality of rare disease registries